Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, Warlow C, Woodward M; Writing Committee for the PROGRESS Collaborative Group. Chapman N, et al. Among authors: bousser mg. Stroke. 2004 Jan;35(1):116-21. doi: 10.1161/01.STR.0000106480.76217.6F. Epub 2003 Dec 11. Stroke. 2004. PMID: 14671247 Clinical Trial.
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
Arima H, Anderson C, Omae T, Woodward M, MacMahon S, Mancia G, Bousser MG, Tzourio C, Rodgers A, Neal B, Chalmers J; Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Collaborative Group. Arima H, et al. Among authors: bousser mg. Stroke. 2012 Jun;43(6):1675-7. doi: 10.1161/STROKEAHA.112.651448. Epub 2012 Apr 24. Stroke. 2012. PMID: 22535269 Clinical Trial.
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, MacMahon S, Chalmers J; PROGRESS Collaborative Group. Arima H, et al. Among authors: bousser mg. Stroke. 2006 Jun;37(6):1497-502. doi: 10.1161/01.STR.0000221212.36860.c9. Epub 2006 Apr 20. Stroke. 2006. PMID: 16627794 Free article.
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, Bousser MG, Anderson C, Mazoyer B, Tzourio C; PROGRESS MRI Substudy Investigators. Dufouil C, et al. Among authors: bousser mg. Stroke. 2009 Jun;40(6):2219-21. doi: 10.1161/STROKEAHA.108.540633. Epub 2009 Apr 23. Stroke. 2009. PMID: 19390070 Clinical Trial.
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
Arima H, Anderson C, Omae T, Woodward M, MacMahon S, Mancia G, Bousser MG, Tzourio C, Harrap S, Liu L, Neal B, Chalmers J; PROGRESS Collaborative Group. Arima H, et al. Among authors: bousser mg. J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1284-5. doi: 10.1136/jnnp-2014-307856. Epub 2014 May 14. J Neurol Neurosurg Psychiatry. 2014. PMID: 24828894 Clinical Trial.
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators. Dufouil C, et al. Among authors: bousser mg. Circulation. 2005 Sep 13;112(11):1644-50. doi: 10.1161/CIRCULATIONAHA.104.501163. Epub 2005 Sep 6. Circulation. 2005. PMID: 16145004
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME; Dipyridamole in Stroke Collaboration (DISC). Leonardi-Bee J, et al. Among authors: bousser mg. Stroke. 2005 Jan;36(1):162-8. doi: 10.1161/01.STR.0000149621.95215.ea. Epub 2004 Nov 29. Stroke. 2005. PMID: 15569877 Review.
A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
Venketasubramanian N, Chen CL, Gan RN, Chan BP, Chang HM, Tan SB, Picard D, Navarro JC, Baroque AC 2nd, Poungvarin N, Donnan GA, Bousser MG; CHIMES Investigators. Venketasubramanian N, et al. Among authors: bousser mg. Int J Stroke. 2009 Feb;4(1):54-60. doi: 10.1111/j.1747-4949.2009.00237.x. Int J Stroke. 2009. PMID: 19236501 Clinical Trial.
549 results